Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: The postoperative radiation therapy in endometrial carcinoma trial

Journal of Clinical Oncology

Volumn 22, Issue 7, 2004, Pages 1234-1241

  Creutzberg, Carlen L ^a   Van Putten, Wim L J ^a   Wárláin Rodenhtiis, Carla C ^a   Van Den Bergh, Alfons C M ^a   De Winter, Karin A J ^a   Koper, Peter C M ^a   Lybeert, Marnix L M ^a   Slot, Annerie ^a   Lutgens, Ludy C H W ^a   Stenfert Kroese, Marika C ^a   Beerinan, Henk ^a   Van Lent, Mat ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOMETRIUM TUMOR; FOLLOW UP; MIDDLE AGED; MORTALITY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE CARE; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 2142640269     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.08.159     Document Type: Article

References (32)

1. Aalders J, Abeler V, Kolstad P, et al: Post-operative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419-427, 1980
2. Meerwaldt JH, Hoekstra CJ, van Putten WL, et al: Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors. Int J Radiat Oncol Biol Phys 18:299-304, 1990
3. Grigsby PW, Perez CA, Kuten A, et al: Clinical stage I endometrial cancer: Prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system, Int J Radiat Oncol Biol Phys 22:905-911, 1992
4. Brady LW, Perez CA, Bedwinek JM: Failure patterns in gynecologic cancer. Int J Radiat Oncol Biol Phys 12:549-557, 1986
5. Poulsen HK, Jacobsen M, Bertelsen K, et al: Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases. Int J Gynecol Cancer 6:38-43, 1996
6. Kucera H, Vavra N, Weghaupt K: Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 38:99-104, 1990
7. Irwin C, Levin W, Fyles A, et al: The role of adjuvant radiotherapy in carcinoma of the endometrium: Results in 550 patients with pathologic stage I disease. Gynecol Oncol 70:247-254, 1998
8. Greven KM, Corn BW: Endometrial cancer. Curr Probl Cancer 21:65-127, 1997
9. Creasman WT, Morrow CP, Bundy BN, et al: Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group Study. Cancer 60:2035-2041, 1987
10. Creutzberg CL, van Putten WL, Koper PC, et al: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial-PORTEC Study Group, Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404-1411, 2000
11. Creutzberg CL, van Putten WL, Koper PC, et al: The morbidity of treatment for patients with stage I endometrial cancer: Results from a randomized trial. Int J Radiat Oncol Biol Phys 51:1246-1255, 2001
12. Greven KM, Randall M, Fanning J, et al: Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 19:529-534, 1990
13. Konski A, Domenico D, Tyrkus M, et al: Prognostic characteristics of surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys 35:935-940, 1996
14. Morrow CP, Bundy BN, Kurman RJ, et al: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 40:55-65, 1991
15. Kasamatsu T, Onda T, Katsumata N, et al: Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 88:245-250, 2003
16. Alektiar KM, McKee A, Lin O, et al: Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO grade 3 cancer? Int J Radiat Oncol Biol Phys 54:79-85, 2002
17. Conn DE, Horowitz NS, Mutch DG, et al: Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 87:243-246, 2002
18. Roberts JA, Brunetto VL, Keys HM: A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOGS99). Gynecol Oncol 68:135, 1998 (abstr 250)
19. Mohan DS, Samuels MA, Selim MA. et al: Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70:165-171, 1998
20. Fanning J, Nanavati PJ, Hilgers RD: Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherapy to node-positive tumors. Obstet Gynecol 87:1041-1044, 1996
21. Kilgore LC, Partridge EE, Alvarez RD, et al: Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56:29-33, 1995
22. Naumann RW, Higgins RV, Hall JB: The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists. Gynecol Oncol 75:4-9, 1999
23. Koh WJ, Tran AB, Douglas JG, et al: Radiation therapy in endometrial cancer. Best Pract Res Clin Obstet Gynaecol 15:417-432, 2001
24. Greven KM, Corn BW, Case D, et al: Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys 39:413-418, 1997
25. Jereczek-Fossa BA: Postoperative irradiation in endometrial cancer: Still a matter of controversy. Cancer Treat Rev 27:19-33, 2001
26. Straughn JM, Huh WK, Orr JW, et al: Stage IC adenocarcinoma of the endometrium: Survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 89:295-300, 2003
27. Rittenberg PV, Lotocki RJ, Heywood MS, et al: High-risk surgical stage I endometrial cancer: Outcomes with vault brachytherapy alone. Gynecol Oncol 89:288-294, 2003
28. Chadha M, Nanavati PJ, Liu P, et al: Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol 75:103-107, 1999
29. Aapro MS, Van Wijk FH, Bolis G, et al: Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 14:441-448, 2003
30. Morrow CP, Bundy BN, Homesley HD. et al: Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group Study. Gynecol Oncol 36:166-171, 1990
31. Randall ME, Brunetto G, Muss H, et al: Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group. Proc Am Soc Clin Oncol 22:2. 2003 (abstr 3)
32. Mundt AJ, McBride R, Rotmensch J, et al: Significant pelvic recurrence in high-risk pathologic stage I-IV endometrial carcinoma patients after adjuvant chemotherapy alone: Implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 50:1145-1153, 2001